News
Impax Laboratories Confirms Patent Challenge Relating to RENVELA®, 2.4 g and 0.8 g (For Suspension) Yahoo/BusinessWire
View ArticleNews
VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study MarketWatch
View ArticleProteon Therapeutics advances drug candidate, sale to Novartis
Proteon Therapeutics advances drug candidate, sale to Novartis Bizjournals.com
View ArticleAffymax, Takeda seek approval of peginesatide in dialysis patients with...
Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease Yahoo/AP
View ArticleAmgen Announces Modifications to U.S. Prescribing Information for Use of...
Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease Yahoo/PR NewsWire
View ArticleFDA recommends lower doses of anemia drugs
FDA recommends lower doses of anemia drugs Yahoo/AP
View ArticleAbbott Reveals Positive Results From Phase-2 Trial Of Kidney Drug
Abbott Reveals Positive Results From Phase-2 Trial Of Kidney Drug RTT News
View ArticleFDA sets date to review Affymax anemia drug
FDA sets date to review Affymax anemia drug Yahoo/AP
View ArticleAffymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies...
Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011 Yahoo/BusinessWire
View ArticleAffymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug Bloomberg
View ArticleUS FDA panel gives positive opinion to Affymax's anaemia drug peginesatide
US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide Pharmabiz
View ArticleDynavax reports final Phase 3 data for HEPLISAV
Dynavax reports final Phase 3 data for HEPLISAV Yahoo/Fly on the Wall
View ArticleAMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of...
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease Enhanced...
View ArticleMultiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell...
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical Seeking Alpha
View ArticleKeryx Patents Seen Overcoming Generic Competition
Keryx Patents Seen Overcoming Generic Competition Investors.com
View ArticleTakeda Withdraws MAA for Omontys in Europe
Takeda Withdraws MAA for Omontys in Europe NASDAQ
View ArticleRockwell Medical: Undervalued After CRUISE-1 Results
Rockwell Medical: Undervalued After CRUISE-1 Results Seeking Alpha
View Article
More Pages to Explore .....